HealthProves
Symptom-centric view

Hyperhidrosis

Substances reporting Hyperhidrosis disproportionately — ranked by ROR.

PainDrug ineffectiveOff label useFatigueDyspnoeaAcute kidney injury
showing 186 of 186
Substance ↓ROR [95% CI]ReportsCategoryLabel
3.5 [2.7–4.6]52algemeennew
2.9 [2.0–4.3]28algemeennew
5.8 [4.5–7.5]61algemeennew
3.0 [2.6–3.3]301algemeennew
2.7 [2.3–3.1]148algemeennew
4.8 [4.7–5.0]3,689algemeennew
4.8 [4.7–5.0]3,689algemeennew
83.1 [79.0–87.4]2,311algemeennew
21.4 [9.1–50.2]6algemeennew
2.8 [2.4–3.2]175algemeennew
21.4 [9.1–50.2]6algemeennew
3.2 [1.8–5.7]12algemeennew
4.1 [2.2–7.4]11algemeennew
4.4 [3.4–5.9]50algemeennew
4.8 [4.5–5.1]1,076algemeennew
3.3 [2.1–5.3]18algemeennew
35.7 [14.7–86.5]6algemeennew
6.6 [2.4–17.8]4algemeennew
2.7 [2.4–2.9]422algemeennew
2.2 [2.1–2.4]624algemeennew
2.9 [2.5–3.2]267algemeennew
9.4 [8.8–10.2]757algemeennew
4.2 [3.4–5.2]94algemeennew
2.6 [2.0–3.3]68algemeennew
2.4 [2.1–2.8]187algemeennew
2.9 [2.7–3.0]1,140algemeennew
3.8 [1.8–8.1]7algemeennew
5.4 [2.2–13.2]5algemeennew
2.5 [2.4–2.6]1,759algemeennew
2.5 [2.5–2.6]3,297algemeennew
3.2 [2.0–5.2]17algemeennew
8.9 [7.1–11.1]81algemeennew
2.7 [2.5–2.9]1,074algemeennew
4.4 [4.1–4.8]601algemeennew
2.5 [1.6–3.9]20algemeennew
4.6 [4.3–4.9]1,044algemeennew
3.9 [3.2–4.9]83algemeennew
8.8 [8.1–9.7]518algemeennew
5.9 [5.4–6.4]560algemeennew
5.2 [4.8–5.6]748algemeennew
3.0 [2.4–3.7]87algemeennew
2.8 [2.4–3.2]183algemeennew
2.8 [2.4–3.2]183algemeennew
4.9 [4.3–5.5]282algemeennew
3.3 [3.2–3.5]1,403algemeennew
6.1 [5.7–6.5]816algemeennew
4.1 [3.1–5.3]59algemeennew
2.3 [1.8–2.9]70algemeennew
3.3 [2.6–4.2]66algemeennew
2.6 [2.2–3.2]101algemeennew
4.4 [3.8–5.2]156algemeennew
2.7 [2.2–3.4]79algemeennew
4.9 [4.1–5.9]121algemeennew
3.4 [2.7–4.3]71algemeennew
3.6 [3.4–3.9]715algemeennew
4.7 [4.5–4.9]2,489algemeennew
4.7 [4.5–4.9]2,506algemeennew
6.9 [5.7–8.4]107algemeennew
2.5 [2.4–2.7]1,828algemeennew
2.5 [2.4–2.7]1,828algemeennew
16.3 [14.9–17.9]516algemeennew
2.5 [1.6–4.1]18algemeennew
3.3 [2.9–3.6]324algemeennew
3.0 [2.8–3.2]679algemeennew
4.2 [3.7–4.9]217algemeennew
4.1 [3.6–4.7]246algemeennew
2.8 [2.6–3.0]686algemeennew
4.7 [4.4–5.1]864algemeennew
4.3 [4.0–4.6]932algemeennew
8.2 [7.0–9.4]185algemeennew
3.0 [2.1–4.4]28algemeennew
5.4 [4.9–5.8]631algemeennew
5.4 [5.0–5.8]633algemeennew
2.3 [2.2–2.4]2,625algemeennew
2.5 [2.4–2.7]1,385algemeennew
8.1 [7.2–9.2]286algemeennew
12.4 [11.4–13.5]557algemeennew
2.9 [2.5–3.3]191algemeennew
2.0 [1.9–2.2]564algemeennew
2.4 [2.3–2.6]817algemeennew
17.3 [16.1–18.5]875algemeennew
5.3 [1.7–16.7]3algemeennew
2.4 [2.2–2.6]467algemeennew
2.4 [2.2–2.6]501algemeennew
4.0 [3.7–4.4]509algemeennew
7.4 [6.0–9.3]83algemeennew
2.8 [2.1–3.8]40algemeennew
9.1 [8.4–9.8]675algemeennew
6.9 [6.0–8.0]190algemeennew
4.1 [3.8–4.5]508algemeennew
4.6 [4.2–5.0]544algemeennew
4.4 [3.9–5.0]246algemeennew
2.6 [2.0–3.4]61algemeennew
7.1 [6.1–8.3]165algemeennew
2.6 [2.2–3.1]129algemeennew
2.3 [1.7–3.1]48algemeennew
3.8 [3.4–4.4]234algemeennew
2.4 [2.3–2.6]1,347algemeennew
21.4 [9.1–50.2]6algemeennew
21.4 [9.1–50.2]6algemeennew
2.5 [1.8–3.6]30algemeennew
2.9 [2.7–3.2]430algemeennew
3.8 [3.1–4.8]83algemeennew
3.7 [3.1–4.5]108algemeennew
3.9 [3.2–4.7]103algemeennew
3.4 [2.8–4.1]102algemeennew
3.4 [2.8–4.1]102algemeennew
3.9 [3.0–5.1]55algemeennew
2.6 [2.5–2.8]2,002algemeennew
2.6 [2.1–3.3]86algemeennew
2.6 [2.5–2.8]2,080algemeennew
9.7 [8.0–11.8]108algemeennew
2.1 [2.0–2.2]1,456algemeennew
7.3 [6.6–8.0]480algemeennew
7.3 [6.6–8.0]480algemeennew
3.5 [3.3–3.7]1,109algemeennew
3.8 [3.0–4.9]68algemeennew
42.8 [38.0–48.1]354algemeennew
5.1 [4.7–5.6]436algemeennew
5.1 [4.7–5.7]437algemeennew
5.1 [4.7–5.7]436algemeennew
2.5 [2.4–2.6]2,070algemeennew
6.5 [6.4–6.7]6,883algemeennew
6.5 [6.4–6.7]6,883algemeennew
3.0 [2.1–4.4]29algemeennew
3.1 [2.8–3.4]361algemeennew
3.1 [1.9–5.2]15algemeennew
7.1 [6.5–7.9]441algemeennew
52.6 [46.1–60.0]296algemeennew
21.4 [9.1–50.2]6algemeennew
21.4 [9.1–50.2]6algemeennew
2.8 [2.7–2.9]1,481algemeennew
2.8 [2.7–2.9]1,481algemeennew
2.9 [2.7–3.0]2,069algemeennew
2.6 [1.9–3.8]31algemeennew
4.6 [3.7–5.8]84algemeennew
2.8 [2.6–3.0]693algemeennew
2.8 [2.6–3.0]764algemeennew
2.9 [2.7–3.1]609algemeennew
2.8 [2.6–3.0]825algemeennew
2.6 [2.0–3.3]65algemeennew
4.8 [4.4–5.1]761algemeennew
4.8 [4.4–5.1]761algemeennew
2.6 [2.1–3.2]82algemeennew
2.1 [1.6–2.6]65algemeennew
9.3 [8.4–10.2]456algemeennew
3.7 [3.4–3.9]1,086algemeennew
4.6 [3.5–6.0]52algemeennew
8.8 [7.8–9.9]274algemeennew
3.9 [3.7–4.1]1,317algemeennew
3.1 [2.5–3.9]85algemeennew
21.4 [9.1–50.2]6algemeennew
3.5 [3.3–3.6]2,192algemeennew
3.3 [3.1–3.4]2,649algemeennew
6.1 [5.5–6.6]519algemeennew
9.1 [7.8–10.5]180algemeennew
2.3 [1.7–3.1]41algemeennew
3.3 [3.0–3.7]381algemeennew
5.0 [4.4–5.7]251algemeennew
38.5 [26.7–55.7]35algemeennew
2.4 [1.6–3.7]22algemeennew
3.4 [2.6–4.5]56algemeennew
3.8 [3.7–4.0]2,487algemeennew
3.3 [3.2–3.5]2,990algemeennew
5.0 [4.6–5.4]716algemeennew
7.3 [5.9–8.9]97algemeennew
4.3 [4.0–4.6]850algemeennew
7.9 [6.0–10.3]55algemeennew
2.8 [2.7–2.9]2,071algemeennew
3.2 [2.7–3.7]143algemeennew
2.0 [1.8–2.4]187algemeennew
3.2 [2.0–5.1]17algemeennew
2.9 [2.2–3.8]54algemeennew
44.5 [39.9–49.8]400algemeennew
2.7 [2.5–2.9]720algemeennew
2.6 [2.4–2.8]790algemeennew
6.7 [6.2–7.2]672algemeennew
291.5 [241.5–352.0]304algemeennew
123.1 [108.3–139.9]413algemeennew
3.0 [2.1–4.4]28algemeennew
4.1 [3.7–4.5]387algemeennew
9.6 [5.2–17.7]11algemeennew
4.0 [3.6–4.5]387algemeennew
3.6 [1.3–9.6]4algemeennew
3.0 [2.3–3.9]56algemeennew
4.0 [3.2–4.9]92algemeennew

ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).